 Oncternal Therapeutics, Inc. Nasdaq: ONCT, a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report its fourth quarter and full year 2019 financial results on March 16, 2020. Oncternals management will host a webcast and conference call at 1:30 p.m. PT 4:30 p.m. ET to discuss the Companys financial results and provide a comprehensive business update. 